CHI will also use the money to invest in health insurance plans, clinically integrated networks and other risk-based initiatives. The $1.7 billion will significantly grow CHI’s debt burden, and credit rating agencies have noticed. Earlier this month, Standard & Poor’s Ratings Services downgraded CHI from “AA-” to “A+” due to the increased debt plans and weaker operating metrics.
Dean Swindle, CFO of CHI, said the debt burden will create some short-term challenges for the system, which has 87 hospitals and more than $12 billion in annual operating revenue. However, he said the plans will “pay dividends down the road” because it is a “vital investment” in CHI’s future.
“CHI’s bold plans are by definition going to create some risk — there is always inherent risk in strategic investment,” Mr. Swindle said in a news release. “But not doing this will create far more risk.”
More Articles on Hospital Finance:
Tenet Closes on $4.3B Vanguard Acquisition
Fitch Upgrades HCA’s Debt After Strong First Half of 2013
Report: Restrictions on Tax-Exempt Bonds Would Damage Hospitals, Economy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
